Acute respiratory infections are the most common reason for physician office visits and antibiotic prescriptions worldwide. The significant overlap in symptoms makes it challenging to differentiate bacterial from non-bacterial infections.
The vast majority of ARIs are caused by non-bacterial etiology, yet 30-80% receive antibiotics. This overprescription is a leading contributor to the global antimicrobial resistance crisis, which currently causes over 1.27 million deaths annually.
FebriDx supports antimicrobial stewardship by giving clinicians an objective, rapid tool to determine whether antibiotics are truly needed — reducing unnecessary prescriptions while ensuring bacterial infections are not overlooked.